Leading The Way in Life Science Technologies. Planning Calendar

Leading The Way in Life Science Technologies. Planning Calendar

Leading The Way in Life Science Technologies 2018 Planning Calendar January 1 Reservation: 11/30/17 Material: 12/7/17 l Kinase Assays l Immunotherapy l Stem-Cell Manufacturing Peptalk, January 8 12, San

Planning Calendar.

2013 Planning Calendar www.genengnews.com January 1 Reservation: 12/6/12 Material: 12/13/12 January 15 Reservation: 12/20/12 Material: 12/28/12 February 1 Reservation: 1/8/13 Material: 1/15/13 February

2014 Planning Calendar

January 1 Reservation: 12/5/13 Material: 12/13/13 January 15 Reservation: 12/19/13 Material: 12/26/13 February 1 Reservation: 1/6/14 Material: 1/13/14 February 15 Reservation: 1/20/14 Material: 1/27/14

Conference Calendar. healthtech.com. January High-Content Analysis January 8-11 San Francisco, CA

High-Content Analysis January 8-11 San Francisco, CA www.highcontentanalysis.com January 2013 PepTalk January 21-25 Palm Springs, CA www.chi-peptalk.com January 24-25 Pipeline 1: Formulation: Optimizing

2009 Planning Calendar. January 15. February 1. January 1. February 15 MEETING DISTRIBUTION AND BONUS CIRCULATION

January 1 Reservation: 12/2/08 Materials: 12/9/08 Special Display Advertiser Bonus Inclusion in exclusive online Biotrends 2009 article January 15 Reservation: 12/16/08 Materials: 12/23/08 Special opportunity

Course Agenda. Day One

Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an

Calendar. The Clear Solution to Reach the Global Biopharma Audience. INTERNATIONAL

The Clear Solution to Reach the Global Biopharma Audience yvdavyd/getty Images & blackred/e+/getty Images 2017 EDITOrial Calendar Editorial Coverage Special Themed Issues January Biopharma Outlook for

Cambridge Healthtech Institute

Cambridge Healthtech Institute Your Life Science Network Conference & Course Catalog March August 2016 CHI is a division of Cambridge Innovation Institute RESEARCH COLLABORATION ADVANCEMENT TABLE OF CONTENTS

Show Schedule 2017/2018

Show Schedule 2017/2018 exhibitors@selectbio.com +44 (0)1787 275642 Woodview, Bull Lane, SUDBURY, CO10 0FD, UK SELECTBIO.com 1 WELCOME Dear Colleague SELECTBIO is pleased to bring you our show schedule

Integrated Media Planning Guide

www.biosciencetechnology.com 2013 Integrated Media Planning Guide 2013 Content Calendar Week 1 Week 2 Week 3 Week 4 Week 5 Imaging Pipettors Equipping Your Lab Biobanking Epigenetics Dyes & Stains January

2012 Classified Media Kit

Genetic Engineering &Biotechnology News Tools Technologies Trends 2012 Classified Media Kit Delivering the Best in Biotech... From Bench to Business Magazine Website e-newsletters List Rental www.genengnews.com

Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER

Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER Forward-Looking Statement Disclaimer In order to take advantage of the safe harbor provisions of the private securities litigation reform

Serving the dynamic informational and networking needs of the global healthcare and life sciences ecosystem for over a decade

Calendar 2018 Serving the dynamic informational and networking needs of the global healthcare and life sciences ecosystem for over a decade For more information on sponsoring, exhibiting, speaking or attending

David A. Gass. Tel

David A. Gass Partner Tel 312.474.6624 dgass@marshallip.com David Gass is a registered patent attorney for biotechnology companies, pharmaceutical companies, diagnostics companies, universities, and research

BioPharma Dealmakers Media Kit SPRINGER NATURE...2 PARTNERING SOLUTIONS...3 OUR AUDIENCE...5 EDITORIAL CALENDARS...6 PROFILE DETAILS...

From the publishers of Nature 2018 Media Kit BioPharma Dealmakers The world s leading publication that connects life science companies to partners and investors. biopharmadealmakers.nature.com SPRINGER

Cancer Research. Peptide Innovations in. Neo-Epitope Analysis Immunotherapy Cancer Proteomics Enzyme Profiling Epigenetics

Peptide Innovations in Cancer Research Neo-Epitope Analysis Immunotherapy Cancer Proteomics Enzyme Profiling Epigenetics Innovative Peptide Solutions Neo-Epitope Analysis Neo-epitopes encoded by the mutanome

2018 RW Baird Health Care Conference. September 5 th, 2018

2018 RW Baird Health Care Conference September 5 th, 2018 1 Forward-looking Statements This presentation and the accompanying oral commentary contain forward -looking statements that involve risks, uncertainties

Specialty Lab Services. Deep science at scale

Specialty Lab Services Deep science at scale Advancing biomarker research Our broad expertise and global laboratory footprint deliver deep science at scale Specialty assays drive insight into preclinical

Cambridge Healthtech Institute

Cambridge Healthtech Institute Your Life Science Network Conference & Course Catalog September 2016 February 2017 CHI is a division of Cambridge Innovation Institute RESEARCH COLLABORATION ADVANCEMENT

SPO GRANTS (2001) PHASES

2002 SPO GRANTS (2001) PHASES MAIN PHASES Legal organisation of the Institute of Biotechnology Ankara University Biotechnology Labs Organisation of Central Lab of the Institute of Biotechnology/ Purchase

2016 Editorial. Advancing Development & Manufacturing. Calendar w w w. P h a r m Te c h. c o m. Editorial coverage

Advancing Development & Manufacturing 2016 Editorial Calendar w w w. P h a r m Te c h. c o m COMPlete Editorial coverage EDITORIAL COVERAGE: EXPERT INSIGHT AND ANALYSIS Pharmaceutical Technology continues

About OMICS Group Conferences

About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of

EDITORIAL CALENDAR. The Science & Business of Biopharmaceuticals INTERNATIONAL

2015 EDITORIAL CALENDAR www.biopharminternational.com Content April Outsourcing Resources This special issue reviews the current state-of-the-industry for biopharmaceutical development and manufacturing

DISCOVERY AND VALIDATION OF TARGETS AND BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMICS. September, 2011

DISCOVERY AND VALIDATION OF TARGETS AND BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMICS September, 2011 1 CAPRION PROTEOMICS Leading proteomics-based service provider - Biomarker and target discovery

Molecular Diagnostics

Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

Antibody Discovery at Evotec

Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic

Media & Press Kit. An Overview of Almac. A Closer Look at Almac Group s Expertise

Media & Press Kit An Overview of Almac A Closer Look at Almac Group s Expertise The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of

Personalized CAR-T Immunotherapy Platform

GLP, GMP, and CLIA-Certified Lab Personalized CAR-T Immunotherapy Platform Accelerate your cancer research and drug discovery Platform Overview 1500 Existing Hybridomas and Antibody Engineering Custom

Basic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.

APPENDIX 2 SURVEY QUESTIONNAIRE Part I. Basic Information I.1 If your company performs biotechnology research and development, uses a biotechnology process in manufacturing, or produces research tools,

THOMAS C. RANSOHOFF Vice President and Principal Consultant

THOMAS C. RANSOHOFF Vice President and Principal Consultant +1.781.281.2704 (o) +1.617.759.4109 (m) transohoff@bptc.com Profile An expert in the development and scale-up of biopharmaceutical processes;

Labcyte Overview. Mark Fischer-Colbrie

MOVING LIQUIDS with SOUND Labcyte Overview Mark Fischer-Colbrie 2016 LABCYTE INC. All rights reserved. Labcyte, Echo, the Labcyte logo are registered trademarks or trademarks of Labcyte Inc., in the U.S.

ADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY BACHELOR OF SCIENCE (Honours) SEMESTER - I

NEW CHOICE BASED CREDIT SYSTEM (TOTAL CREDIT = 22+22+28+28+26+26 = 152) Type of the Paper Paper Code ADAMAS UNIVERSITY FACULTY OF SCIENCE - DEPARTMENT OF BIOTECHNOLOGY SEMESTER - I / Brief Contents I BT1201

Centre for NanoHealth

Steve Conlan PhD An integrated collaborative base for businesses in Wales Director - Reproductive Biology & Cancer Research Institute of Life Science School of Medicine Unique interdisciplinary R&D environment,

Cambridge Healthtech Institute

Cambridge Healthtech Institute Your Life Science Network Conference & Course Catalog August 2015 February 2016 Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, MA 02494 T: (781) 972-5400

Sustaining long-term growth by focusing on our customers

Strategy in action Sustaining long-term growth by focusing on our customers Our capabilities and customer focused strategy are opening growth opportunities in addressable markets of approximately $8 billion.

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298

DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES March 2017. March 2017 ABA 298 1 Technologies, Products & Services

Dav Partner. vid A. Gass INDUSTRIES. assists clients. Best Lawyers. edition of The. in America in the Corporate. Patent Prosecution.

Dav Partner vid A. Gass Tel 312.474.6624 dgass@marshallip.comm David Gass is a registered patent attorney for biotechnology companies, pharmaceutical companies, diagnostics companies, universities, and

2009 INVESTOR DAY. BioPharmaceuticals. Ken Frank President BioPharmaceuticals December 17, Sustainable, Profitable Growth

2009 INVESTOR DAY BioPharmaceuticals Ken Frank President BioPharmaceuticals December 17, 2009 Sustainable, Profitable Growth Life Sciences FY 2009 Total Sales $2,329.2 (amounts shown in millions) BioPharmaceuticals

Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends ( )

Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends (2013-2021) May, 2017 3 rd Edition Information contained in this market report is believed to be reliable at the time

TRIANNI Media Kit MEDIA CONTACT CORPORATE HEADQUARTERS. Trianni, Inc. San Francisco, CA

TRIANNI Media Kit CORPORATE HEADQUARTERS Trianni, Inc. San Francisco, CA Telephone: 1.866.374.9314 MEDIA CONTACT Mandy Boyd Director of Marketing @Trianni_mAb Website: Trianni.com TECHNOLOGY LEADERSHIP

DEEP SEQUENCING FORUM December 5-6, 2018 Auditorium at Merck Research Labs - Boston, MA

Deep Sequencing and Related Technologies for Drug Development and Clinical Trial Applications Deep sequencing data is of critical importance in complementing phenotypic and clinical data sets to develop

AKESOgen, Inc, 3155 Northwoods Place, NW, Norcross, GA 30071, USA Tel: +1 (770) Page 1

Page 1 HLA Sequencing Based Typing Workflow: A- Sample Collection: iswab-discovery (Mawi DNA Technologies) - Sample was transported by standard US postal services mail, no cold chain of any sort was involved

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development

Downing - Keio Summer School 2018 Healthcare and Biotechnology Course Outline page 1 Strand A: Healthcare and Biotechnology Course Outline This course aims to provide an overview of the current challenges

Corporate Presentation. September 6th, 2018

Corporate Presentation September 6th, 2018 Forward Looking Statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than

Cancer ImmunoTherapy Accelerator (CITA) Dr Shalini Jadeja

Cancer ImmunoTherapy Accelerator (CITA) Dr Shalini Jadeja The Vision To develop an integrative London initiative that emerges as the UK hub for immunotherapy of cancer focusing on: Safe and effective

Genetic Engineering in Agriculture

Details Utah State University Engineering in This is a project resulting from the Engineering Workshop for Teachers to provide teaching materials for genetic engineering topics. Please direct any feedback

the PLATFORM Pipeline in Lyon AREA

the PLATFORM Pipeline in Lyon AREA Do you have development or partnership projects in Life Sciences? Are you interested in developing your business in France? This overview is designed to give you an idea

Integrated M.Tech. in Biotechnology (B.Tech + M.Tech) programme. Semester 1

Annexure-VI Integrated M.Tech. in Biotechnology (B.Tech + M.Tech) programme Semester 1 CY101/PH102 Engineering Chemistry/ Engineering Physics 3 1 0 4 MA103 Basic Mathematics 3 1 0 4 CS101 Computer Programming-I

Biopharmaceuticals A Regulatory Perspective

Biopharmaceuticals A Regulatory Perspective Maeve Lally Senior Pharmaceutical Assessor (Biologics) CASSS CMC Forum Killarney May 2017 Cead Mile Fáilte A hundred thousand welcomes 26/06/2017 2 Disclaimer

Impact Factor Journals in Biotechnology & Applied Microbiology

Impact Factor Journals in Biotechnology & Applied Microbiology Indexed in ISI Web of Knowledge (JCR 2016) Compiled by: Arslan Sheikh In Charge Reference & Research Section Library Information Services

227 AP and >100 CDx engagements

Anatomic pathology Q 2 Solutions comprehensive in-house end-to-end anatomic pathology and adjunct molecular services are designed to meet your clinical trial needs. Anatomic pathology is a vital part of

SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM

SNP GENOTYPING Accurate, sensitive, flexible MassARRAY System SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM Biomarker validation Routine genetic testing Somatic mutation profiling Up to 400

SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM

SNP GENOTYPING Accurate, sensitive, flexible MassARRAY System SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM Biomarker validation Routine genetic testing Somatic mutation profiling Up to 400

India as an Outsourcing Frontier in Biotechnology

1 India as an Outsourcing Frontier in Biotechnology K.V. Subramaniam President & CEO 3 rd Annual Biotech Supply Chain Academy Conference San Francisco Oct 26, 2010 Biotechnology Industry Issues Long gestation

36 th Annual JP Morgan Healthcare Conference. January 11 th, 2018

36 th Annual JP Morgan Healthcare Conference January 11 th, 2018 1 Forward-looking Statements This presentation and the accompanying oral commentary contain forward -looking statements that involve risks,

2018 EDITORIAL COVERAGE. Connecting the Pharma Industry for 28 Years.

2018 EDITORIAL COVERAGE Connecting the Pharma Industry for 28 Years EDITORIAL COVERAGE: EXPERT INSIGHT AND ANALYSIS Pharmaceutical Technology Europe sets the standard for publishing independent, industry-leading

Examination Assignments

Bioinformatics Institute of India BIOINFORMATICS INSTITUTE OF INDIA C-56A/28, Second Floor, Sector-62, Noida-201301, UP. INDIA Tel.: 0120-4320801 / 02, M. 09818473366, 09810535368 Email: info@bii.in, Website:

AIT - Austrian Institute of Technology

BIOMARKER DISCOVERY, BIOINFORMATICS, AND BIOSENSOR DEVELOPMENT Technology Experience AIT Austrian Institute of Technology Low-Emission Transport AIT - Austrian Institute of Technology Energy Health & Bioresources

Market Research at the NCBC Library

Market Research at the NCBC Library North Carolina Biotechnology Center Library 15 T.W. Alexander Drive, Research Triangle Park Phone: 919-549-8880 E-mail: library@ncbiotech.org The reports in this list

Welcome to all Delegates Biotechnology for Pharmaceutical and Health Classification of Biotechnology Conventional Is a technique that makes use of living organism for specific purpose eg: bread/cheese

Market Research at the NCBiotech Library

Market Research at the NCBiotech Library The library's subscriptions include selected reports from BCC Research and Kalorama Information. Abstracts and Tables of Contents are freely available online from

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital

Trend in diagnostic biochip development Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital Handling of the early stage is important for

to acquire Investor And Analyst Call Presentation January 4, 2008

to acquire Investor And Analyst Call Presentation January 4, 2008 Safe Harbor Statement The following information contains, or may be deemed to contain, forward looking statements (as defined in the U.S.

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Overview Serving biotech and pharma community since 1998 Proven track record of advancing small molecules from

to precision medicine

QIAGEN at the AMP 2018 Annual Meeting yourpath Discover to precision medicine Sample to Insight Discover your path to precision medicine Lead the way with QIAGEN, from Sample to Insight Every day, data

Advances with Acoustics

Advances with Acoustics Evolution of Acoustic Dispensing and Next Generation Developments SLAS Europe Compound Management March 14, 2017 2016 LABCYTE INC. All rights reserved. Labcyte, Echo, the Labcyte

EY Life Sciences. Key themes from The Next Frontiers in Precision Medicine panel. February 2016

EY Life Sciences Key themes from The Next Frontiers in Precision Medicine panel February 2016 Evolution of precision medicine One-size-fits-all therapeutics Precision medicine Disconnected health care

The Biotechnology Industry. Chapter 1: Background

The Biotechnology Industry Chapter 1: Background What Is Biotechnology? Biotechnology = technology based on biology in the broadest definition Any technological application that uses biological systems,

Protein research and bioinformatics

Protein research and bioinformatics LauritzenConsulting Content and application Proteins are the fundamental building blocks of life. Research in Greater Copenhagen focuses on the significance of proteins

Explore the World of End-to-End. Integrated Lab Performance

Explore the World of End-to-End Integrated Lab Performance Come explore the largest, wholly owned network of BioPharma dedicated laboratories in the world. Discovery/Pharmacology Pre-Clinical/Early Development

Jefferies Healthcare Conference. June 7 th, 2017

Jefferies Healthcare Conference June 7 th, 2017 1 Forward-looking Statements This presentation and the accompanying oral commentary contain forward -looking statements that involve risks, uncertainties

CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY

CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY Executive Summary Prepared for Applied Biological Technologies Initiative Economic and Workforce Development Program California

Custom Antibodies & Recombinant Proteins

Custom Antibodies & Recombinant Proteins INTRODUCTION Custom services to meet your research and development requirements Improvements in health, medicine and diagnostics over the past century can be largely

ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, USA, CA,

SCIENCE CITATION INDEX - GENETICS & HEREDITY - JOURNAL LIST Total journals: 95 1. ADVANCES IN GENETICS Irregular ISSN: 0065-2660 ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, USA, CA,

New Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation

New Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation Dr. Klaus Suwelack Johnson & Johnson Innovation, Janssen-Cilag Germany, Neuss

IK4 BIOTECHNOLOGY & BIOMATERIALS. Research Alliance.

IK4 Research Alliance BIOTECHNOLOGY & BIOMATERIALS www.ik4.es BIOTECHNOLOGY AND BIOMATERIALS, CROSS-CUTTING TECHNOLOGIES The biotechnology and biomaterials fields are characterised by the fact that they

AH SEMINAR DAY. Advanced Technologies. Molecular Techniques. Advanced. Molecular. Oncology Pharmacogenetics. Techniques for Complex Analysis

AH SEMINAR DAY 19 speakers 300 participants 8 hours September 6, 2018 YOU ARE INVITED - ENJOY FREE ENTRY! Oncologyand and Oncology Pharmacogenetics Pharmacogenetics Molecular Molecular Techniques Techniques

Personalised Medicine Regulatory Issues

Personalised Medicine Regulatory Issues INFRAFRONTIER / IMPC Stakeholder Meeting Presented by Marisa Papaluca on 14 November 2017 Senior Scientific Advisor, Scientific Committees Regulatory Science Strategy

SPONSORSHIP OPPORTUNITIES

CONFERENCES SPONSORSHIP OPPORTUNITIES 12th Annual Conference on Stem Cell and Gene Therapy March 11-12, 2019 Bali, Indonesia our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme

Konica Minolta to Acquire Invicro (US)

Konica Minolta to Acquire Invicro (US) Acceleration of expansion of precision medicine business Offering new value for drug discovery and development in immuno-oncology and neurodegenerative disease September

Overview of the current Japanese biotech industry and investment outlook

Overview of the current Japanese biotech industry and investment outlook Daiwa SMBC Capital Co.,Ltd Hiroki Narita Deputy General Manager E-mail:narita@daiwasmbc-cap.co.jp Biotechnology Market in Japan

Introducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration

Introducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration 1 2 Translational Informatics Overview Precision s suite of services is

Single-Cell Genomics Deep insights into complex biology

Single-Cell Genomics Deep insights into complex biology Cellular Heterogeneity is a Fundamental Feature of Biological Systems Development Adult Tissues Disease Individual cells behave differently from

UNIT OUTLINE. Biotechnology 331. Unit Code Unit Coordinator: Dr Keith Gregg. Semester School of Biomedical Sciences

Unit Code 307698 Biotechnology 331 Unit Coordinator: Dr Keith Gregg School of Biomedical Sciences UNIT OUTLINE Semester 1 2012 CRICOS (Perth - 00301J) (Sydney - 02637B) Table of Contents INTRODUCTION...

Policy and Development of Biotechnology: Bangladesh Perspective. N. Choudhury Bangladesh Academy of Sciences

Policy and Development of Biotechnology: Bangladesh Perspective N. Choudhury Bangladesh Academy of Sciences WCS Recommendation National policies should be adopted that imply consistent and long term support

Synthetic Biology. Sustainable Energy. Therapeutics Industrial Enzymes. Agriculture. Accelerating Discoveries, Expanding Possibilities. Design.

Synthetic Biology Accelerating Discoveries, Expanding Possibilities Sustainable Energy Therapeutics Industrial Enzymes Agriculture Design Build Generate Solutions to Advance Synthetic Biology Research

Department of Systems Biotechnology

Department of Systems Biotechnology DNA Genome, transcriptome mrna & Proteome Protein Gene & Protein Interaction Protein Networks Informational Pathways Cells Network of Cells Organism Ecosystem Organismal

WELCOME. Norma J. Nowak, PhD Executive Director, NY State Center of Excellence in Bioinformatics and Life Sciences (CBLS)

WELCOME Norma J. Nowak, PhD Executive Director, NY State Center of Excellence in Bioinformatics and Life Sciences (CBLS) Director, UB Genomics and Bioinformatics Core (GBC) o o o o o o o o o o o o Grow

Pharmaceuticals and Biotechnology

ABCD Pharmaceuticals and yet are quickly accessible from one central location. 7 Gain a competitive advantage 7 Facilitate product research and development 7 Raise return on investment Pharmaceuticals

Mutation analysis in cell-free DNA from cancer patients

Mutation analysis in cell-free DNA from cancer patients dr. Anneleen Beckers project manager & product manager at Biogazelle CRIG s digital PCR mini-symposium, May 15, 2018 2018 Biogazelle. All rights

Introduction to Biotechnology and Bioprocess Engineering A Course for the Chemical Engineering Curriculum

Introduction to Biotechnology and Bioprocess Engineering A Course for the Chemical Engineering Curriculum Michael Gyamerah and Irvin W. Osborne-Lee, Chemical Engineering Department, Prairie View A&M University,

TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT

Specialist in tissue analysis by Histology, Immunohistochemistry and In Situ Hybridization TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT CONTENTS Histalim: who we are Our areas of expertise

Illumina Diagnostics. Emily Winn-Deen, PhD Vice President, Product Development Diagnostics

Introduction ti to Illumina Diagnostics Emily Winn-Deen, PhD Vice President, Product Development Diagnostics 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life,

INTERFACE OF NUCLEAR AND BIOTECHNOLOGIES

INTERFACE OF NUCLEAR AND BIOTECHNOLOGIES By Vienna 28 Sept. 2005 Introduction Ways in which nuclear technology has been used in recent biomedical applications. Coherent synergies between nuclear techniques

J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION

J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION J ove VIDEO JOURNAL The first scientific video journal dedicated to advancing science by increasing reproducibility and efficient

The Power to Cure: Therapeutic Innovation in Academia

The Power to Cure: Therapeutic Innovation in Academia Leslie Molony, Ph.D. November 7, 2011 Sanford-Burnham Medical Research Institute: a Non Profit Basic Research Institute Santa Barbara Est. 2006 La

TREE CODE PRODUCT BROCHURE

TREE CODE PRODUCT BROCHURE Single Molecule, Real-Time (SMRT) Sequencing technology offers: Long read sequencing ~10 Gb with 20 kb average read lengths for WGS ~20 Gb with 40 kb average read length for

FDA Oversight of Gene Therapy

FDA Oversight of Gene Therapy Celia M. Witten, Ph.D., M.D. Deputy Director, FDA CBER Rare Disease and Orphan Products Breakthrough Summit NORD October 17, 2016 Hyatt Regency Crystal City Crystal City,

KNIME as a Platform for Integrated Hit Finding at Novartis. Patrick S. Lee Ph.D. KNIME Fall Summit 2016 San Francisco 9/16/2016

KIME as a Platform for Integrated Hit Finding at ovartis Patrick S. Lee Ph.D. KIME Fall Summit 2016 San Francisco 9/16/2016 Agenda Overview of ovartis Hit finding in drug discovery KIME integration 2 A

Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis

Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis -Collaboration to explore use of mrna Therapeutics to treat the underlying cause of CF